Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
10/2003
10/21/2003US6635430 Comprised of polypropylene and polytetrafluoroethylene; opening on bottom surface; pegs; grooves on side and bottom surface; useful in high-throughput screening assays for assessing binding of macromolecules to proteins
10/21/2003US6635427 Kit for use in the amplification and quantification of preferential sequences
10/21/2003US6635423 Informative nucleic acid arrays and methods for making same
10/21/2003US6635422 Partitioning cellular ribonuclic acid protein structures; incubate sample with ligand, form complex on solid upport, remove ribonuclic acid complex from support
10/21/2003US6635420 Purification of substances from a biological sample
10/21/2003US6635419 Using target-specific primers which contain a binding segment and a mobility-reducing moiety; reacting with primer extension reagent; separating electrophoretically using a sieving matrix and detecting signal
10/21/2003US6635416 Screening methods for identifying viral proteins with interferon antagonizing functions and potential antiviral agents
10/21/2003US6635415 Nitric oxide gas detector
10/21/2003US6635260 Composition comprising carrier and at least one non-toxigenic strain of Clostridium difficile which does not produce toxins A and B, from selected groups defined by restriction endonuclease analysis of total genomic DNA on agarose gels
10/21/2003US6635259 Purified and isolated polypeptide having specified amino acid sequence; used for diagnosing active infection with enterohemorrhagic E.coli
10/21/2003US6635257 Oligomeric particle having diameter of 1 to 100 nanometer and consisting of hepatitis C virus envelope proteins, or parts thereof, in which at least one cysteine is alkylated
10/21/2003US6635251 Eotaxin-specific antibodies
10/21/2003US6635225 Automatic stainer for staining objects for microscopic examination
10/21/2003US6635224 Online monitor for polymer processes
10/21/2003US6635172 Apparatus for the enhancement of water quality in a subterranean pressurized water distribution system
10/21/2003US6635167 Medical equipment having batteries, terminals, displays used for sampling glucose and/or blood
10/21/2003US6635147 Method for analyzing boron-containing alkaline pulping liquors
10/21/2003US6634523 Pepper agent system
10/21/2003US6634243 Sample testing device
10/21/2003US6634216 Inspection method for sealed package
10/21/2003US6634213 A hydrogen-permeable coating is applied to a semiconductor wafer containing hydrogen sensor dies, prior to dicing of the wafer. The permeable coating is an organic spin-on polymer, and hydrogen sensors preferably include hydrogen-sensing
10/21/2003CA2341231C Instrument for selecting and depositing multicellular organisms and other large objects
10/21/2003CA2294516C Ikk-.beta. proteins, nucleic acids and methods
10/21/2003CA2238245C Microbiological test panel and method therefor
10/21/2003CA2145288C An apparatus for examining carcases
10/21/2003CA2106962C Polypeptides from mycobacterium paratuberculosis
10/21/2003CA2093896C Hormone labelling with rhenium and technetium
10/21/2003CA2076432C Humanized antibody derivatives that recognize difucosyl lewis blood group antigens y-6 and b-7-2
10/21/2003CA2056278C Washing solution, which contains a complexing agent for metal ions, for a solid-phase immunometric method, and the use thereof
10/21/2003CA2053924C Synthetic pseudomonas aeruginosa pilin peptide and related vaccines and diagnostics
10/16/2003WO2003085752A2 Molehole embedded 3-d crossbar architecture used in electrochemical molecular memory device
10/16/2003WO2003085585A1 A method for gene mapping from genotype and phenotype data
10/16/2003WO2003085406A2 Anti-thrombomodulin autoantibody as a thrombosis marker
10/16/2003WO2003085405A1 Method for selecting bioactive agents by detecting variation induced in cyclic amp intracellular concentration of a sensitive living cell
10/16/2003WO2003085404A1 Methods for detecting ovarian cancer
10/16/2003WO2003085403A1 Method and device for trichomonas detection
10/16/2003WO2003085402A1 Test piece for chromatography and process for producing the same
10/16/2003WO2003085401A1 Device and method to simultaneously detect different antibodies and antigens in clinical alimentary and environmental samples
10/16/2003WO2003085400A1 Onset of force development as a marker of thrombin generation
10/16/2003WO2003085399A1 Method of judging leukemia, pre-leukemia or aleukemic malignant blood disease and diagnostic therefor
10/16/2003WO2003085398A1 Method of estimating risk of dental decay, apparatus of esitmating risk of dental decay, system of esitmating risk of dental decay and program of esitmating risk of dental decay
10/16/2003WO2003085396A2 Device and method for controlling the composition of a gaseous atmosphere
10/16/2003WO2003085393A1 Method of simultaneous fractional analysis of peracetic acid and hydrogen peroxide
10/16/2003WO2003085392A1 Analytical appliance cartridge with retrieval mechanism, and set of the cartridge and analyzer
10/16/2003WO2003085380A1 Sidestream gas sampling system with detachable sample cell
10/16/2003WO2003085375A2 Hcv antiviral and cytotoxicity drug screening assay
10/16/2003WO2003085373A2 A system for the detection of pathogens in the mail stream
10/16/2003WO2003085372A2 Biosensor membranes composed of polymers containing heterocyclic nitrogens
10/16/2003WO2003085179A2 Spinning preparation machine with microwave sensors
10/16/2003WO2003085134A2 Methods of diagnosing and treating colorectal cancer
10/16/2003WO2003085130A1 Association of edg5 polymorphism v286a with type ii diabetes mellitus and venous thrombosis/pulmonary embolism and the use thereof
10/16/2003WO2003085127A2 Method for identification of insulin receptor kinase activators
10/16/2003WO2003085125A1 Use of biomolecular targets in the treatment and visualization of brain tumors
10/16/2003WO2003085124A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/16/2003WO2003085106A1 Preventives and/or remedies for cancer
10/16/2003WO2003085098A2 Identification of virulence associated regions rd1 and rd5 enabling the development of improved vaccines of m. bovis bcg and m. microti
10/16/2003WO2003085096A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/16/2003WO2003085090A2 A human ribonucleotide reductase m2 subunit
10/16/2003WO2003085086A2 Motif-grafted hybrid polypeptides and uses thereof
10/16/2003WO2003085079A1 Cell culture system, apparatus for checking cultured cells and apparatus for culturing cells
10/16/2003WO2003084994A2 Use of biological photoreceptors as directly light-activated ion channels
10/16/2003WO2003084982A2 Functionalized compositions for improved immobilization
10/16/2003WO2003084869A2 Method for separating single-wall carbon nanotubes and compositions thereof
10/16/2003WO2003084540A2 Compositions comprising mmp7 modulators for the treatment of chronic pain
10/16/2003WO2003084480A2 HAUSP-p53 INTERACTION AND USES THEREOF
10/16/2003WO2003084475A2 INHIBITORS OF THE S100-p53 PROTEIN-PROTEIN INTERACTION AND METHOD OF INHIBITING CANCER EMPLOYING THE SAME
10/16/2003WO2003084465A2 Modeling biological systems
10/16/2003WO2003084445A1 Device for mixing and/or injecting cements
10/16/2003WO2003084388A2 Early detection of sepsis
10/16/2003WO2003084384A2 Diagnosis of flavivirus infection
10/16/2003WO2003084333A1 Visualization and quantitiation of cellular cytotoxicity using cell-permeable fluorogenic protease substrates and caspase activity indicator markers
10/16/2003WO2003073910A3 Assays for cancer patient monitoring based on levels of analyte components of the plasminogen activator system in body fluid samples
10/16/2003WO2003073238A3 Computational method for designing enzymes for incorporation of amino acid analogs into proteins
10/16/2003WO2003073104A3 Diagnostic and therapeutic use of ma onconeuronal antigens for neurodegenerative diseases
10/16/2003WO2003070976A3 Methods for determining the influence of protein binding on antiretroviral activity
10/16/2003WO2003070973A3 Single cell assessment of viral infection/replication
10/16/2003WO2003068813A3 Group b streptococcus antigen
10/16/2003WO2003066876A9 An apparatus and methods for using biological material to discriminate an agent
10/16/2003WO2003065875A3 Method and test strips for the measurement of fat loss during weight loss programs
10/16/2003WO2003062826A3 Materials and methods for examining and treating nasopharyngeal carcinoma
10/16/2003WO2003062803A3 Method for quantitative video-microscopy and associated system and computer software program product
10/16/2003WO2003062786A3 Biosensor for small molecule analytes
10/16/2003WO2003057258A3 Quantitative ranking of transient ligand binding to target biomolecules
10/16/2003WO2003056292A3 Detection of odours using insects
10/16/2003WO2003054549A3 Method of mass spectrometry
10/16/2003WO2003054517A3 Methods for detecting half-antibodies using chip-based gel electrophoresis
10/16/2003WO2003053204A3 Method for cleaning a soiled article
10/16/2003WO2003052416A3 Focussed antibody technology
10/16/2003WO2003051905A3 Taojiks as modifiers of the beta-catenin pathway and methods of use
10/16/2003WO2003050556A3 Assay device and method
10/16/2003WO2003049677A3 Mesoporous permeation layers for use on active electronic matrix devices
10/16/2003WO2003048902A3 Library screening
10/16/2003WO2003048772A3 Detection d'autoanticorps reactifs aux molecules antigenes d'ilots pancreatiques et/ou a l'insuline Detection of autoantibodies reactive molecules to antigens of pancreatic islets and / or insulin
10/16/2003WO2003048387A3 Labelled nucleotides
10/16/2003WO2003046560B1 Self-assembly molecules
10/16/2003WO2003046148A3 Polypeptide quantitation
10/16/2003WO2003046144A3 Microscale immobilization of molecules using a hydrogel and methods of use thereof
10/16/2003WO2003041565A3 Method for diagnosis of helicobacter pylori infection
10/16/2003WO2003040727A3 Use of oxidic nanoparticles
10/16/2003WO2003040406A3 Diagnosis of clinical infection of a wound
1 ... 2484 2485 2486 2487 2488 2489 2490 2491 2492 2493 2494 2495 2496 2497 2498 2499 2500 2501 2502 2503 2504 ... 3937